Immediate and long-term consequences of coronavirus disease 2019 on fertility and androgenic status of men

Abstract

BACKGROUND: The new coronavirus disease 2019 (COVID-19) recognized as a global pandemic, impacts many human organs and systems. In view of the coronavirus widespread and high incidence of the disease in young men of reproductive potential, It would be relevant to assess the immediate and long-term consequences of coronavirus disease on the reproductive system of men and their hormonal status

AIM: To study of the effect of COVID-19 on the male reproductive system and hormonal status.

MATERIALS AND METHODS: The study included the findings of examination and treatment of 62 men aged 22 to 45 years (mean age: 38.3 ± 3.2 years) who had COVID-19 confirmed by PCR testing within 3-6 months prior to the study. Sixteen (25.8%) men had severe disease, and 46 (74.2%) men suffered from moderate one. All patients enrolled in the study had spermogram parameters, mixed antiglobulin reaction (MAR) test findings and total plasma testosterone levels were within the reference values before the disease. These parameters were determined for all patients after recovery at 6 and 12 months.

RESULTS: Six months after the disease, significant spermatogenesis disorders, manifested by a decreasing concentration and/or mobility and/or the number of normal forms of spermatozoa, leukospermia, were observed in 14 of 16 (87.5%) patients in the severe disease group and in 16 of 46 (34.7%) patients with moderate severity disease (p < 0.05). Total plasma testosterone levels were decreased in all 16 (100%) patients in the severe group and in 32 of 46 (69.6%) patients in the moderate group (p < 0.05). Within 12 months after the disease, significant disorders in the main spermogram parameters were observed in 5 of 16 (31.2%) patients with severe coronavirus disease, and in 4 of 46 (8.7%) patients with moderate coronavirus (p < 0.05). A decrease in total plasma testosterone levels occurred in 10 of 16 (62,5%) men of the severe disease group and in 4 of 46 (8.7%) men with moderate disease (p < 0.05).

CONCLUSIONS: Our findings demonstrate the negative impact of COVID-19 on male fertility and hormonal status. The coronavirus severity mainly determines the rate, intensity and duration of spermatogenesis disorders and hypogonadism manifestations that occur after it.

Keywords

coronavirus disease / COVID-19 / fertility / testosterone / spermogram / MAR-test

References

[1] www.who.int [Internet]. Novel coronavirus (2019-nCoV). Situation report-1. WHO bulletin. January 21, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn= 20a99c10_4

[2] www.who.int [Электронный ресурс]. Novel coronavirus (2019-nCoV). Situation report-1. WHO bulletin. January 21, 2020. Режим доступа: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4

[3] www.who.int [Internet]. Novel coronavirus (2019-nCoV). Situation report-1. WHO bulletin. January 21, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn= 20a99c10_4

[4] Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5): 667–673. doi: 10.1016/j.jiph.2020.03.019

[5] Harapan H., Itoh N., Yufika A., et al. Coronavirus disease 2019 (COVID-19): a literature review // J Infect Public Health. 2020. Vol. 13, N 5. P. 667–673. doi: 10.1016/j.jiph.2020.03.019

[6] Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5): 667–673. doi: 10.1016/j.jiph.2020.03.019

[7] Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X

[8] Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome // Lancet Respir Med. 2020. Vol. 8, N 4. P. 420–422. doi: 10.1016/S2213-2600(20)30076-X

[9] Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi: 10.1016/S2213-2600(20)30076-X

[10] Giri M, Puri A, Wang T, Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci Prog. 2021;104(1):368504211000906. doi: 10.1177/00368504211000906

[11] Giri M., Puri A., Wang T., Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis // Sci Prog. 2021. Vol. 104, N 1. ID 368504211000906. doi: 10.1177/00368504211000906

[12] Giri M, Puri A, Wang T, Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci Prog. 2021;104(1):368504211000906. doi: 10.1177/00368504211000906

[13] Howell CR, Zhang L, Yi N, et al. Associations between cardiometabolic disease severity, social determinants of health (SDoH) and poor COVID-19 outcomes. Obesity (Silver Spring). 2022;30(7): 1483–1494. doi: 10.1002/oby.23440

[14] Howell C.R., Zhang L., Yi N., et al. Associations between cardiometabolic disease severity, social determinants of health (SDoH) and poor COVID-19 outcomes // Obesity (Silver Spring). 2022. Vol. 30, N 7. P. 1483–1494. doi: 10.1002/oby.23440

[15] Howell CR, Zhang L, Yi N, et al. Associations between cardiometabolic disease severity, social determinants of health (SDoH) and poor COVID-19 outcomes. Obesity (Silver Spring). 2022;30(7): 1483–1494. doi: 10.1002/oby.23440

[16] Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ open. 2021;11(1):e044640. doi: 10.1136/bmjopen-2020-044640

[17] Pijls B.G., Jolani S., Atherley A., et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies // BMJ open. 2021. Vol. 11, N 1. ID e044640. doi: 10.1136/bmjopen-2020-044640

[18] Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ open. 2021;11(1):e044640. doi: 10.1136/bmjopen-2020-044640

[19] Vahedian-Azimi A, Pourhoseingholi MA, Saberi M, et al. Gender susceptibility to COVID-19 mortality: Androgens as the usual suspects? In: Guest PC, editor. Clinical, biological and molecular aspects of COVID-19. Advances in experimental medicine and biology. Vol. 1321. Springer, Cham; 2021. P. 261–264. doi: 10.1007/978-3-030-59261-5_23

[20] Vahedian-Azimi A., Pourhoseingholi M.A., Saberi M., et al. Gender susceptibility to COVID-19 mortality: Androgens as the usual suspects? В кн.: Clinical, biological and molecular aspects of COVID-19. Advances in experimental medicine and biology. Vol. 1321 / P.C. Guest, editor. Springer, Cham, 2021. P. 261–264. doi: 10.1007/978-3-030-59261-5_23

[21] Vahedian-Azimi A, Pourhoseingholi MA, Saberi M, et al. Gender susceptibility to COVID-19 mortality: Androgens as the usual suspects? In: Guest PC, editor. Clinical, biological and molecular aspects of COVID-19. Advances in experimental medicine and biology. Vol. 1321. Springer, Cham; 2021. P. 261–264. doi: 10.1007/978-3-030-59261-5_23

[22] Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi: 10.1016/j.cell.2020.02.052

[23] Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor // Cell. 2020. Vol. 181, N 2. P. 271–280.e8. doi: 10.1016/j.cell.2020.02.052

[24] Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi: 10.1016/j.cell.2020.02.052

[25] Parmar MS. TMPRSS2: An equally important protease as ACE2 in the pathogenicity of SARS-CoV-2 infection. Mayo Clin Proceed. 2021;96(11):2748–2752. doi: 10.1016/j.mayocp.2021.07.005

[26] Parmar M.S. TMPRSS2: An equally important protease as ACE2 in the pathogenicity of SARS-CoV-2 infection // Mayo Clin Proceed. 2021. Vol. 96, N 11. P. 2748–2752. doi: 10.1016/j.mayocp.2021.07.005

[27] Parmar MS. TMPRSS2: An equally important protease as ACE2 in the pathogenicity of SARS-CoV-2 infection. Mayo Clin Proceed. 2021;96(11):2748–2752. doi: 10.1016/j.mayocp.2021.07.005

[28] Wan Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells. Cells. 2020;9(4):920. doi: 10.3390/cells9040920

[29] Wan Z., Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells // Cells. 2020. Vol. 9, N 4. ID 920. doi: 10.3390/cells9040920

[30] Wan Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells. Cells. 2020;9(4):920. doi: 10.3390/cells9040920

[31] Li D, Jin M, Bao P, et al. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292

[32] Li D., Jin M., Bao P., et al. Clinical characteristics and results of semen tests among men with coronavirus disease 2019 // JAMA Netw Open. 2020. Vol. 3, N 5. ID e208292. doi:10.1001/jamanetworkopen.2020.8292

[33] Li D, Jin M, Bao P, et al. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292

[34] Pan F, Xiao X, Guo J, et al. No evidence of SARS-CoV-2 in semen of males recovering from COVID-19. Fertil Steril. 2020;113(6): 1135–139. doi: 10.1016/j.fertnstert2020.04.024

[35] Pan F., Xiao X., Guo J., et al. No evidence of SARS-CoV-2 in semen of males recovering from COVID-19 // Fertil Steril. 2020. Vol. 113, N 6. P. 1135–139. doi:10.1016/j.fertnstert2020.04.024

[36] Pan F, Xiao X, Guo J, et al. No evidence of SARS-CoV-2 in semen of males recovering from COVID-19. Fertil Steril. 2020;113(6): 1135–139. doi: 10.1016/j.fertnstert2020.04.024

[37] Song C, Wang Y, Li W, et al. Absence of 2019 novel coronavirus in semen and testis of COVID-19 patients. Biol Reprod. 2020;103(1):4–6. doi: 10.1093/biolre/ioaa050

[38] Song C., Wang Y., Li W., et al. Absence of 2019 novel coronavirus in semen and testis of COVID-19 patients // Biol Reprod. 2020. Vol. 103, N 1. P. 4–6. doi: 10.1093/biolre/ioaa050

[39] Song C, Wang Y, Li W, et al. Absence of 2019 novel coronavirus in semen and testis of COVID-19 patients. Biol Reprod. 2020;103(1):4–6. doi: 10.1093/biolre/ioaa050

[40] Xu J, Qi L, Chi X, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol Reprod. 2006;74(2):410–416. doi: 10.1095/biolreprod.105.044776

[41] Xu J., Qi L., Chi X., et al. Orchitis: a complication of severe acute respiratory syndrome (SARS) // Biol Reprod. 2006. Vol. 74, N 2. P. 410–416. doi: 10.1095/biolreprod.105.044776

[42] Xu J, Qi L, Chi X, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol Reprod. 2006;74(2):410–416. doi: 10.1095/biolreprod.105.044776

[43] Liu W, Han R, Wu H, Han D. Viral threat to male fertility. Andrologia. 2018;50(11):e13140. doi: 10.1111/and.13140

[44] Liu W., Han R., Wu H., Han D. Viral threat to male fertility // Andrologia. 2018. Vol. 50, N 11. ID e13140. doi: 10.1111/and.13140

[45] Liu W, Han R, Wu H, Han D. Viral threat to male fertility. Andrologia. 2018;50(11):e13140. doi: 10.1111/and.13140

[46] Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi: 10.1001/jama.2020.3786

[47] Wang W., Xu Y., Gao R., et al. Detection of SARS-CoV-2 in different types of clinical specimens // JAMA. 2020. Vol. 323, N 18. P. 1843–1844. doi: 10.1001/jama.2020.3786

[48] Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi: 10.1001/jama.2020.3786

[49] Lardone MC, Piottante A, Valdevenito R, et al. Histological and hormonal testicular function in oligo/azoospermic infertile men. Andrologia. 2013;45(6):379–385. doi: 10.1111/and.12026

[50] Lardone M.C., Piottante A., Valdevenito R., et al. Histological and hormonal testicular function in oligo/azoospermic infertile men // Andrologia. 2013. Vol. 45, N 6. P. 379–385. doi: 10.1111/and.12026

[51] Lardone MC, Piottante A, Valdevenito R, et al. Histological and hormonal testicular function in oligo/azoospermic infertile men. Andrologia. 2013;45(6):379–385. doi: 10.1111/and.12026

[52] Moore BJB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925

[53] Moore B.J.B., June C.H. Cytokine release syndrome in severe COVID-19 // Science. 2020. Vol. 368, N 6490. P. 473–474. doi: 10.1126/science.abb8925

[54] Moore BJB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925

[55] Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17(1):7–19. doi: 10.1007/s10522-015-9578-8

[56] Frasca D., Blomberg B.B. Inflammaging decreases adaptive and innate immune responses in mice and humans // Biogerontology. 2016. Vol. 17, N 1. P. 7–19. doi: 10.1007/s10522-015-9578-8

[57] Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17(1):7–19. doi: 10.1007/s10522-015-9578-8

[58] Temiz MZ, Dincer MM, Hacibey I, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia. 2020;53(2):e13912. doi: 10.1111/and.13912

[59] Temiz M.Z., Dincer M.M., Hacibey I., et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study // Andrologia. 2020. Vol. 53, N 2. ID e13912. doi: 10.1111/and.13912

[60] Temiz MZ, Dincer MM, Hacibey I, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia. 2020;53(2):e13912. doi: 10.1111/and.13912

[61] Falahieh FM, Zarabadipour M, Mirani M, et al. Effects of moderate COVID-19 infection on semen oxidative status and parameters 14 and 120 days after diagnosis. Reprod Fertil Dev. 2021;33(12):683–690. doi: 10.1071/rd21153

[62] Falahieh F.M., Zarabadipour M., Mirani M., et al. Effects of moderate COVID-19 infection on semen oxidative status and parameters 14 and 120 days after diagnosis // Reprod Fertil Dev. 2021. Vol. 33, N 12. P. 683–690. doi: 10.1071/rd21153

[63] Falahieh FM, Zarabadipour M, Mirani M, et al. Effects of moderate COVID-19 infection on semen oxidative status and parameters 14 and 120 days after diagnosis. Reprod Fertil Dev. 2021;33(12):683–690. doi: 10.1071/rd21153

[64] Gacci M, Coppi M, Baldi E, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod. 2021;36(6):1520–1529. doi: 10.1093/humrep/deab026

[65] Gacci M., Coppi M., Baldi E., et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 // Hum Reprod. 2021. Vol. 36, N 6. P. 1520–1529. doi: 10.1093/humrep/deab026

[66] Gacci M, Coppi M, Baldi E, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod. 2021;36(6):1520–1529. doi: 10.1093/humrep/deab026

[67] Dashko AA, Elagin VV, Kiseleva YuYu, et al. Impact of COVID-19 and other viral infections of male fertility (preliminary data). Russian Journal of Human Reproduction. 2020;26(6):8388. EDN: PHIPYS doi: 10.17116/repro20202606183

[68] Дашко А.А., Елагин В.В., Киселева Ю.Ю., и др. Влияние новой коронавирусной инфекции на мужскую фертильность (предварительные данные) // Проблемы репродукции. 2020. Т. 26, № 6. С. 83–88. EDN: PHIPYS doi: 10.17116/repro20202606183

[69] Dashko AA, Elagin VV, Kiseleva YuYu, et al. Impact of COVID-19 and other viral infections of male fertility (preliminary data). Russian Journal of Human Reproduction. 2020;26(6):8388. EDN: PHIPYS doi: 10.17116/repro20202606183

[70] Enikeev D, Taratkin M, Morozov A, et al. Prospective two-arm study of the testicular function in patients with COVID-19. Andrology. 2022;10(6):1047–1056. doi: 10.1111/andr.13159

[71] Enikeev D., Taratkin M., Morozov A., et al. Prospective two-arm study of the testicular function in patients with COVID-19 // Andrology. 2022. Vol. 10, N 6. P. 1047–1056. doi: 10.1111/andr.13159

[72] Enikeev D, Taratkin M, Morozov A, et al. Prospective two-arm study of the testicular function in patients with COVID-19. Andrology. 2022;10(6):1047–1056. doi: 10.1111/andr.13159

RIGHTS & PERMISSIONS

Eco-Vector